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Introduction
The world population is ageing at an accelerated pace (Bloom et al. 2015) , which implies a rise in chronic non-communicable diseases. Many of the processes involved in these age-related illnesses start at an early stage (e.g. 30 years; Michalakis et al. 2013) , and the identification of the time at which the alterations first manifest may allow more effective interventions. Rapid urbanization, changes in eating habits and decreased physical activity increase the incidence and prevalence of chronic diseases in the elderly population . Physical inactivity is estimated to cause 6% of coronary artery disease, 7% of type 2 diabetes mellitus and 10% of breast cancers and colon cancer (Lee et al. 2012) , diseases whose prevalence also increases with ageing (Michalakis et al. 2013) . Also, the lack of exercise might be responsible for 9% of premature mortality (Lee et al. 2012) .
Spontaneous physical activity (SPA) is an important component of energy homeostasis and comprises all daily life physical activities other than purposeful volitional exercise, such as ambulation, working, playing, climbing stairs and dancing (Villablanca et al. 2015) . The energy expenditure of SPA is called non-exercise activity thermogenesis (NEAT) and is the predominant component of the activity thermogenesis (SPA plus volitional exercise), ranging from 15% of total daily energy expenditure in very sedentary people to 50% in active individuals (Levine, 2004; Novak & Levine, 2007) . High levels of NEAT improve metabolic parameters in type 2 diabetes mellitus (Hamasaki et al. 2013; Villablanca et al. 2015) , reduce the risk for cardiovascular events and all-cause mortality (Katzmarzyk et al. 2009; Villablanca et al. 2015) and protect from weight gain when excess calories are consumed (Levine et al. 1999) . Like other components of energy homeostasis, SPA is centrally controlled, but its neural mediators are still not fully known (Teske et al. 2008) . Several brain areas and molecules seem to regulate SPA (Teske et al. 2008) . As the master regulator of energy balance (Waterson & Horvath, 2015) , the hypothalamus is involved (Villablanca et al. 2015) . Among the modulators, the neuropeptide orexin is one of the most studied, and it is known to increase SPA (Kotz et al. 2006; Zink et al. 2014) , but many other factors also participate (Novak & Levine, 2007) . Intracerebroventricular administration of insulin has been shown to increase SPA in lean but not in diet-induced obese mice, which were centrally resistant to this hormone (Hennige et al. 2009 ). Likewise, pharmacological inhibition of hypothalamic insulin signalling in mice also decreased locomotor activity (Bandaru et al. 2010) . With respect to leptin, weight-matched ob/ob mice were half as active as wild-type mice (Clark & Gay, 1972) , and restoration of leptin receptor in hypothalamic pro-opiomelanocortin neurons increased SPA in the highly hypoactive db/db mice despite the severe obesity (Huo et al. 2009 ). Finally, An et al. (2015) showed that brain-derived neurotrophic factor (BDNF) neurons in the anterior paraventricular hypothalamus inhibit feeding and stimulate locomotor activity .
As we age, there is a reduction in hypothalamic insulin sensitivity (García-San Frutos et al. 2007 and leptin (Scarpace et al. 2000a,b; Shek & Scarpace, 2000; Sahu, 2004; Balaskó et al. 2014) , and there seems to be a decline in BDNF levels (Silhol et al. 2005) . Moreover, age is inversely correlated with the level of physical activity (Westerterp, 2000; Westerterp & Meijer, 2001) . Therefore, we investigated here the age at which the initial phase of decline in locomotor activity occurs in mice and whether it is associated with the emergence of hypothalamic insulin and leptin resistance and reduced BDNF expression.
Methods

Ethical approval
The animal procedures were strictly conducted according to the Arouca Law (no. 11.794/8 October 2008) and the Normative Resolutions of the National Council for Animal Experiments Control (CONCEA), both regulated by Brazilian Federal Constitution. All experiments described in this manuscript were approved by the Institutional Ethics Committee on Animal Use (CEUA no. 8191200114) of the Federal University of Sao Paulo (UNIFESP), Brazil. The experimental work was performed by investigators who understand the ethical principles of the journal, and the work presented here is in accordance with the journal's ethics checklist.
Animals
Male C57Bl/6 mice were obtained from the Center for Development of Animal Models for Medicine and Biology (CEDEME, Federal University of São Paulo). They were kept at the animal house of the Department of Bioscience in a temperature-controlled room (22°C) with a 12 h-12 h light-dark cycle (lights on 07.00-19.00 h) and free access to water and a standard diet with the following composition: 16.5% fat, 65.7% carbohydrate, 17.7% protein and a caloric density of 3.82 kcal g −1 . All mice were allowed to acclimate to the animal house for 2 weeks before commencement of any experiments. At the end of the experiment, mice were anaesthetized with a mixture of ketamine (Dopalen, 100 mg kg −1 , 1.0 ml kg −1 ; Ceva, Paulinia, São Paulo, Brazil) and xylazine (Anasedan, 10 mg kg −1 , 0.5 ml kg −1 ; Ceva) administered I.P., and all mice were killed by decapitation.
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Experimental groups
Three groups of mice were used, according to their age at the end of the experiment: 4 (4M), 6 (6M) and 10 months old (10M). For the 10M group there were two sets of mice, with n = 10 in each (final n = 20). The first set was used for SPA and indirect calorimetry analysis only, whereas the second set, besides SPA, was used for all other analysis together with the 4M and 6M groups. The 4M (n = 10) and 6M (n = 10) groups were included in the study in such a way that mice would be 4 and 6 months old, respectively, by the time the last set of mice would complete 10 months (10M group). Mice were kept in collective cages (three or four mice each), except during the 48 h SPA and indirect calorimetry analysis for the 10M group and for food intake measurement for the 4M and 6M groups, after which they returned to the collective cages, always with the same cage mates.
Body weight and food intake
Body weight and food intake were measured for the three groups at the end of the study. Average daily food consumption was determined individually by subtracting the weight of the remaining food after 48 h from the weight of food given, with care being taken to account for spillage. For the 10M group, food intake was determined during SPA measurement.
Spontaneous physical activity
Spontaneous physical activity was measured individually by infrared beam sensors (Teske et al. 2008 ) using an infrared actimeter system composed of a two-dimensional (x-and y-axes) square frame (25 cm × 25 cm), each frame containing 16 × 16 infrared beams separated 1.3 cm from each other (Panlab-Harvard Apparatus, Barcelona, Spain). Spontaneous physical activity was recorded in mice in the 10M group, every month, from the 4th to the 10th month of age, for 48 h consecutively. The software ActiTrack v2.7 (Panlab-Harvard Apparatus) allowed the determination of SPA, distance travelled and average speed of displacement. Spontaneous physical activity consisted of the sum of stereotypical movements and locomotion. The software determines stereotypes by the number of samples where the position of the mouse is different from its position during the previous sample and equal to its position from the second sample and determines locomotion by the number of samples where the position of the mouse is different from its position during the previous sample and different from the position of the second sample. Distance travelled is locomotion (expressed in centimetres), and average speed (in centimetres per second) is calculated as the distance travelled divided by the time mice spent in locomotion. Spontaneous physical activity was analysed as the areas under the curves of activity for each mice using the trapezoidal method (Matthews et al. 1990) . Spontaneous physical activity, distance travelled and average speed of displacement were determined for the dark phase of the cycle, and the values are the average of the two dark phases in a 48 h period.
Indirect calorimetry
Indirect calorimetry was analysed in the 10M group for 48 h, every month, from the 4th to the 10th month of age, at room temperature (22°C) using an indirect calorimetry system. In short, mice were placed individually in the specifically designed calorimeter chambers (Oxylet System; Panlab-Harvard Apparatus) with free access to diet and water. Oxygen consumption, carbon dioxide production and energy expenditure were calculated using the software Metabolism (Panlab-Harvard Apparatus). Data for energy expenditure (in kilocalories per day) were analysed as areas under the curves of energy expenditure for the dark phases (average of the two dark phases in the 48 h period) calculated from values of each mice using the trapezoidal method (Matthews et al. 1990 ).
Intraperitoneal glucose (ipGTT) and insulin tolerance tests (ipITT)
Both ipGTT and ipITT were performed in the same groups of mice, respecting a minimal interval of 48 h between the tests. For the ipGTT, after checking fasting blood glucose (8 h fasting) with Accu-Check Advantage II (Roche, Indianapolis, IN, USA), a solution of 40% glucose [2.0 g (kg body weight) −1 , 5 ml kg −1 ] was administered into the peritoneal cavity. Blood glucose was measured again 15, 30, 60 and 120 min after glucose injection. The ipITT was performed after a 6 h fasting. Blood glucose was determined before and 4, 8, 12 and 16 min after insulin injection I.P. [0.5 U (kg body weight) −1 , 5 ml kg −1 ] using Accu-Check Advantage II. For both tests, blood samples were taken by tail venesection. Mice were conscious, and fasting started at 07.00 h. Results are presented as the area under the curve (AUC) of blood glucose during ipGTT and ipITT, calculated using the trapezoidal method (Matthews et al. 1990 ).
Fat pads
Post mortem, retroperitoneal and epididymal fat depots were excised and weighed.
Plasma analyses
Blood was obtained in the morning, when the mice were killed, from mice fasted for 12 h. As described in Western blot procedures below, at the time of killing, mice received either saline or insulin. Plasma analyses were performed only for saline-injected mice. Trunk blood was collected in Eppendorf tubes containing heparin (1:1000 dilution). Plasma was obtained by centrifugation (3,000 × g for 10 min) and stored at -80°C for determination of insulin (EZRMI-13K | Rat/Mouse Insulin ELISA; Merck Millipore, Darmstadt, Germany) and leptin (EZML-82K | Rat/Mouse Leptin ELISA; Merck Millipore).
Western blot
Mice fasted for 12 h were anaesthetized with a mixture of ketamine (Dopalen, 100 mg kg −1 ; Ceva) and xylazine (Anasedan, 10 mg kg −1 ; Ceva) diluted in saline. After confirming anaesthesia by the loss of pedal reflex (toe pinch), mice received either saline or regular insulin (100 µl, 10 IU) through the vena cava in the peritoneal cavity (Costa Júnior et al. 2015) . After 5 min, mice were killed by decapitation. For dissection of the hypothalamus, a transverse section was made at the level of the optic chiasma, which delimits the anterior part of the hypothalamus, and passed through the anterior commissure, which was used as a horizontal reference. The line between the posterior hypothalamus and mammillary bodies was used as the caudal limit (Glowinski & Iversen, 1966) . The hypothalamus was then homogenized in a solubilization buffer [1% Triton X-100, 100 mM Tris (pH 7.5), consisting of 10 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium orthovanadate, 2.0 mM phenylmethylsulfonyl fluoride and 1.0 µg ml −1 of aprotinin]. Samples were centrifuged at 4°C for 30 min for removal of insoluble material. The protein concentration of each supernatant was measured using the Bradford method. Samples containing 50 or 40 µg (for BDNF) of protein were separated by SDS-PAGE and transferred to nitrocellulose membranes. The antibodies used to probe the blots were as follows: Akt1/2/3 (Santa Cruz, CA, USA; sc81434; 1:1000), Thr308-phospho-Akt (Santa Cruz; sc16646; 1:1000), Y705-phospho-STAT3 (Cell Signaling, Beverly, MA, USA; #9131; 1:1000), STAT3 (Cell Signaling; #9139: 1:1000) and BDNF (Abcam, Cambridge, MA, USA; EPR1292; 1:500). Akt1/2/3, Thr308-phospho-Akt, Y705-phospho-STAT3 and STAT3 were analysed in the hypothalamus of mice receiving either insulin or saline, and BDNF was determined only in the hypothalamus of saline-receiving mice. GAPDH (Santa Cruz; sc166545; 1:500) was used as a loading control. The proteins were detected using enhanced chemiluminescence (SuperSignal West Pico; Pierce Biotechnology, Rockford, IL, USA) after 2 h of incubation with a horseradish peroxidase-conjugated secondary antibody (diluted 1:10,000 in 1% skimmed milk; Invitrogen, Carlsbad, CA, USA). The immunoreactive bands were revealed using enhanced chemiluminescence reagents (Pierce Biotechnology), detected with an LAS-3000 CCD camera (Fuji, Tokyo, Japan). For densitometry, ImageJ software (National Institutes of Health, Bethesda, MD, USA) was used.
Muscle morphometric analyses
The gastrocnemius muscle (medial portion) was dissected immediately after the mice were killed. The muscle was fixed in 10% phosphate-buffered formalin solution for 24 h, washed in water for 30 min and then immersed in alcohols (in ascending order), followed by xylol and embedded in Paraplast R (Histosec R , Merck, Darmstadt, Germany). After embedding, 5-µm-thick histological sections were obtained and stained with Haematoxylin and Eosin. The cross-sectional area of muscle fibres (in micrometres squared) and cell density of cross-sections (number of muscle fibres per millimetre squared) were determined. The histological sections were photographed and analysed with an Axio Vision monitor installed in an inverted microscope Axio Observer.D1 Zeiss R 1 (Zeiss, Hamburg, Germany).
Statistical analyses
Results are shown as means ± SD. All analyses were performed using the software Statistica v.12 (Statsoft, Palo Alto, CA, USA). Repeated-measures ANOVA was used for evaluation of spontaneous physical activity (including distance travelled and average speed of locomotion). For energy expenditure, a repeated-measures ANCOVA was used, and ANCOVA was performed for daily food intake and weight of the fat pads. All had body weight as a covariate. For the other parameters, one-way ANOVA was used. The Newman-Keuls post hoc test was used when necessary. Significance was set at P < 0.05.
Results
Body weight, food intake and adiposity
Body weight increased significantly with age [F(2,26) = 24.30, P < 0.0001]. It was higher in the 6M and 10M groups compared with the 4M group, with no difference between 6M and 10M. Daily food intake and the weight of the fat depots were analysed by an ANCOVA with body weight as a covariate. Accounting for body weight, there was an effect of age for daily food intake, which was higher in the 6M compared with the 10M group (P = 0.009). The weights of both epididymal and retroperitoneal adipose tissue were similar among the groups when body weight was used as covariate (Table 1) . 
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Glucose homeostasis and insulin sensitivity
There was a trend for an increase in fasting blood glucose with age [F(2,26) = 2.58, P = 0.09]. The AUC of blood glucose during ipGTT was affected by age [F(2,26) = 9.63, P = 0.0007]. The AUC during ipGTT was higher in the 6M and 10M groups when compared with the 4M group. No difference was found between the 6M and 10M groups. The AUC of blood glucose during ipITT was similar among the groups (Table 1) .
Plasma insulin and leptin
Plasma concentrations of both insulin and leptin were not affected by age (Table 1) .
Spontaneous physical activity, distance travelled and average speed of displacement
There was an effect of age on SPA [F(6,18) = 10.43, P < 0.0001], distance travelled [F(6,19) = 11.64, P < 0.0001] and average speed of locomotion [F(6,19) = 11.89, P < 0.0001], all of which declined as the mice grew older (Fig. 1A-C) . The decrease started when mice were 6 months old and persisted until the end of the experiment. Compared with 4 months of age, SPA decreased ß12% when the mice were 6-7 months old and ß28% when they were 8-10 months old (Fig. 1A) . The distance travelled and speed of locomotion decreased ß25% in 6-month-old mice compared with when they were 4 months old, and the magnitude of this decrease remained throughout the time studied, except for month 7, when both distance and speed of displacement increased to 85% of the value of month 4 ( Fig. 1B-C) . The initial difference between the reduction in SPA (12%) and distance travelled (25%) indicates that locomotion decreases first rather than stereotyped or repetitive behaviour, as SPA is the sum of both.
Energy expenditure
Energy expenditure (EE) was evaluated with body weight as a covariate. No effect of body weight on EE was observed.
As for SPA and the other parameters of locomotion, energy expenditure also decreased as an effect of ageing [F(6,49) = 16.193, P < 0.001]. The reduction became more evident from the 8th month, but there was a transient reduction in EE in the 5th month. Except for month 5 compared with month 10, in the last 3 months (8-10 months) EE was smaller than in the first 4 months (4-7 months). Energy expenditure decreased ß30% when mice were 8-9 months old and 14% when they were 10 months old compared with the beginning of the study (Fig. 2) . Curiously, EE increased in the last (10th) month compared with the previous 2 months (8th and 9th).
Expression of hypothalamic mediators of energy homeostasis
To evaluate insulin signalling in the hypothalamus, Akt phosphorylation and total Akt expression were determined in I.V. saline-or insulin-injected mice (Fig. 3A-C) . No effect of either age or insulin administration was observed for Akt phosphorylation, total Akt expression or for the phosphorylated Akt/total Akt ratio. Phosphorylated and total STAT3 protein expression were used to evaluate leptin signalling in the hypothalamus. Data for either saline-or insulin-injected mice were analysed and are presented together, because after 5 min I.V. insulin administration neither the amount of total STAT3 nor STAT3 phosphorylation was affected. There was a significant decrease in the amount of phosphorylated STAT3 as an effect of age [F(2,25) = 3.98, P = 0.03]. The phosphorylated STAT3 was reduced in the 6M and 10M groups compared with the 4M group (Fig. 4A) . ANOVA, however, did not find any difference for the total abundance of STAT3 (Fig. 4B) . No difference in the phosphorylation status of STAT3 between the 6M and 10M groups was observed (Fig. 4A) . The phosphorylated STAT3/total STAT3 ratio was similar among the groups (Fig. 4C) .
The expression of BDNF in the hypothalamus, evaluated only in the saline-injected mice, was not affected during the time span studied, as no difference among the groups was found (Fig. 5) .
Cross-sectional area of muscle fibres and cell density of cross -sections
To exclude a possible role of alteration in skeletal muscle on the decrease in SPA during ageing, cross-sectional area (Fig. 6A ) and the cell density of cross-sections of the gastrocnemius (Fig. 6B) were evaluated. The cross-sectional area and cell density analysis were similar among the groups.
Discussion
Considering population ageing, the accompanying decline in physical activity (Sprod et al. 2015) and the impact of physical inactivity on morbidity and mortality (Lee et al. 2012) , a better understanding of the mechanisms controlling SPA could offer alternative approaches to combat sedentary behaviour and the pathologies associated with low levels of physical activity.
In our study, we found a significant decrease in SPA, distance travelled and speed of locomotion as mice aged from 4 to 10 months. The decline started when mice were only 6 months old. There are few studies with respect to SPA and ageing, and the use of different methodologies makes comparisons difficult (Teske et al. 2014b ). However, Teske et al. (2012) also demonstrated that SPA started to decrease at a similar age in obesity-resistant and Sprague-Dawley rats. Six-month-old mice are considered middle aged (Flurkey et al. 2007; Stowie & Glass, 2015) , 
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thus the underlying changes leading to reduced physical activity start at an early stage.
The reduction in SPA, as well as in the other parameters of locomotion, was accompanied by a downregulation in hypothalamic leptin signalling. In both 6M and 10M groups, tyrosine STAT3 phosphorylation was reduced when compared with younger (4M) mice. We performed the STAT3 analysis in both saline-and insulin-injected mice. Despite the cross-talk between the insulin and leptin signalling pathways (Carvalheira et al. 2005), in agreement with our results it has been shown that STAT3 phosphorylation at the tyrosine residue is not affected by insulin within the 2-15 min time frame (Carvalheira et al. 2005) . Pelleymounter et al. (1995) were among the first to report the effects of leptin on locomotor activity by demonstrating that daily I.P. leptin injection increased locomotor activity and metabolic rate in ob/ob mice. This effect, however, was not observed in lean wild-type mice (Pelleymounter et al. 1995) . Coppari et al. (2005) also reported the importance of leptin in locomotor activity in Lepr neo/neo mice (Coppari et al. 2005) , and Choi et al. (2008) demonstrated that intracerebroventricular leptin administration increased SPA and reduced food and water intake (Choi et al. 2008) .
Interestingly, plasma leptin was similar during the time span investigated, suggesting that the decreased hypothalamic signalling in 6-and 10-month-old mice might have been caused by a compromised ability of leptin to cross the blood-brain barrier. In fact, El-Haschimi et al. (2000) demonstrated that the first abnormality in leptin signalling in diet-induced obese mice is reduced transport of leptin through the blood-brain barrier, which later evolves to an intracellular signalling defect in hypothalamic neurons (El-Haschimi et al. 2000) . Worth mentioning, even though not statistically significant (P = 0.09), the 45% reduction in the amount of hypothalamic STAT3 protein content in 10-month-old mice compared with the 6-month-old group could indicate that a further deterioration of leptin signalling is taking place.
In addition to leptin, other molecules appear to modulate SPA (Novak & Levine, 2007; Teske et al. 2008 Teske et al. , 2014a . We postulated a role for hypothalamic insulin signalling and BDNF as mediators of the age-associated decline in SPA, as both have already been shown to be involved in SPA regulation (Hennige et al. 2009; Bandaru et al. 2010; An et al. 2015) and are also affected by age (Silhol et al. 2005; García-San Frutos et al. 2007 . In our study, insulin signalling did not decrease in mice from 4 to 10 months of age in both basal and stimulated conditions. However, I.V. insulin failed to increase Akt phosphorylation significantly compared with saline 5 min Abbreviations: 4M, 4-month-old group; 6M, 6-month-old group; and 10M, 10-month-old group. Values are expressed as means + SD. One-way ANOVA, with Newman-Keuls post hoc test. * P < 0.05. Leptin signalling was determined in both saline-and insulin-injected mice. As there was no effect of insulin in A, B or C, data were analysed and are presented together (n = 9 or 10 mice per group).
after injection. García-San Frutos et al. (2007; observed a reduction in insulin signalling in 8-month-old Wistar rats 15 min after intracerebroventricular insulin but not vehicle injection. Thus, the route of administration and the time point at which the hypothalamus was analysed might explain the discrepancy among the studies and the reason we did not see an increase in Akt phosphorylation after insulin stimulation. Although it has been shown that when the I.V. route is used 5 min or less is suitable for peripheral insulin-stimulated Akt phosphorylation (Arrandale et al. 1996; Yagishita et al. 2017) , a longer interval might be required to detect changes centrally (Carvalheira et al. 2005) , which limits the interpretation of our results after insulin stimulation. For BDNF, our results are in accordance with those of Silhol et al. (2005) , who did not find decreased BDNF expression in the hypothalamus of rats from 4 to 10 months. Our findings do not exclude, however, an involvement of both insulin and BDNF in SPA regulation at a later stage. Importantly, however, there is a vast list of potential neuroendocrine modulators of SPA (Novak & Levine, 2007) , including orexin, which has also been shown to be affected by age (Sawai et al. 2010) . Thus, additional studies analysing the SPA pattern in parallel with those factors could shed new light into the mechanisms of SPA regulation during ageing. Remarkably, at the same time as SPA, distance travelled and speed of locomotion started to the decrease, there was a worsening of glucose homeostasis. By decreasing the number of daily steps in young healthy men from 6000 or 10,000 to 1500 for 2-3 weeks, Olsen et al. (2008) found metabolic changes suggestive of insulin resistance and attenuation of postprandial lipid metabolism. Also, there was an increase in intra-abdominal fat without changes in total fat mass (Olsen et al. 2008) . Using a similar approach, Krogh-Madsen et al. (2010) found, besides insulin resistance, a decrease in maximal oxygen consumption and in the lean mass of the legs (Krogh-Madsen et al. 2010) . Moreover, the elevated SPA, characteristic of obesity-resistant rats, protected them from gaining fat compared with their Sprague-Dawley controls over a period of 18 months (Teske et al. 2012) . Thus, the detrimental metabolic effects of reducing ambulatory activity cannot be overlooked.
Despite the decline in physical activity first appearing at 6 months of age, the decrease in energy expenditure (except for a transient reduction at the 5th month) did not occur until the reduction in SPA became more evident, i.e. at 8 months of age. As a limitation of our study, the energy expenditure we measured included not only activity thermogenesis but also basal metabolic rate, the thermic effect of food and the energy cost for thermoregulation (Garland et al. 2011) . Thus, although we cannot fully attribute the changes in energy expenditure to the reduction in SPA, based on thermodynamics a decrease in physical activity implies a reduction in energy expenditure (Teske et al. 2012) . Consequently, the greater reduction in physical activity, in terms of both quantity and intensity (speed), certainly contributed to less energy being expended, as is also known from studies in humans (Levine, 2004; Krogh-Madsen et al. 2010) .
We also assessed whether changes in skeletal muscle could be associated with the decline in SPA, but the morphometric analysis found no difference for the time span investigated. Thus, our results suggest that the initial decrease of physical activity at an early age seems to be triggered within the CNS. As mice get older, however, this chronically lower level of SPA could impact skeletal muscle in a negative fashion, because it has been demonstrated that elevated SPA can preserve fat-free mass through ageing (Teske et al. 2012 ).
In conclusion, our study showed that the amount and intensity of SPA started to decline at an early stage during ageing, and this reduction was accompanied by a decrease in hypothalamic leptin signalling. Of note, by the time SPA started to decrease, glucose intolerance emerged, highlighting the need to counteract the reduction of physical activity during ageing to prevent metabolic complications. A better understanding of the central mechanisms involved in SPA regulation could offer alternative approaches to combat sedentary behaviour.
